抗生素的使用及其对正常微生物群的影响
1Division of Translational Medicine, Department of Medicine, New York University Langone Medical Center (NYULMC), New York, NY 10016, USA. Department of Microbiology, NYULMC, New York, NY 10016, USA. Department of Veterans Affairs New York Harbor Medical Center, New York, NY 10010, USA.
概括
抗生素通过治疗感染和预防传播影响个人和社区健康. 但它们也会增加抗药性,损害人体有益的微生物群,
科学领域:
- 微生物学
- 药理学
- 公共卫生
背景情况:
- 抗感染药物,尤其是抗生素,
- 它们的使用与个人健康利益和公共健康考虑相交, 包括传染病原体的传播.
- 抗生素耐药性是一种已知的后果, 越来越限制严重感染的治疗选择.
研究的目的:
- 阐明使用抗生素的多方面影响.
- 突出抗生素作用之前被低估的"第四个边缘" - - 人类微生物组的附带损害.
- 强调微生物群的重要性,
主要方法:
- 对抗生素效应的概念分析.
- 对抗生素的历史和最新科学理解的回顾.
- 对抗生素影响的"四刃剑"类比的讨论.
主要成果:
- 通过对抗感染, 抗生素为个人和社区带来好处.
- 抗生素耐药性对公众健康构成重大和日益严重的威胁.
- 抗生素会对宿主微生物组造成附带损害,对个体健康产生负面影响.
结论:
- 抗生素的全部影响包括个人治疗,社区健康,耐药性发展和微生物组的破坏.
- 了解抗生素对微生物的作用的"第四边缘"对于全面的健康策略至关重要.
- 这种与微生物群的共生关系对健康至关重要, 在早期发育过程中特别敏感, 容易受到抗生素引起的损害.
更多相关视频
相关概念视频
Antibiotic Selection
62.0K
Overview
62.0K
Clinical Significance of Antibiotic Resistance
10
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
10
Introduction to the Human Microbiota
28
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
28
Mechanism of Antibiotic Resistance in MRSA
44
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
44
Development of Human Microbiota
9
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
9
Development of Antibiotic Resistance
1.9K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K


